Abstract
Pentabromoethylbenzene (PBEB), as one of the novel brominated flame retardants (NFBRs), has caused increasing public concern on health risks. Till now, information regarding potential effects of PBEB on thyroid dysfunction remains unclear. Herein, we investigated thyroid disruption of PBEB in vitro and in silico and evaluated thyroid dysfunction induced by PBEB using Sprague-Dawley rats. PBEB showed thyroid receptor (TR) β antagonistic activity with IC50 of 9.82×10-7 M in dual-luciferase reporter gene assay and induced relative reorientation of helix 11 (H11) and H12 of TR ligand binding domain as revealed by molecular dynamics simulations. PBEB (0.2, 2, 20 mg/kg BW/d) markedly altered transcriptome profile of thyroid with induction of 17, 42, and 119 differentially expressed genes (DEGs) involved in thyroid hormone signaling and synthesis pathway, of which transthyretin and albumin are common DEGs. The 28-d exposure to PBEB significantly decreased triiodothyronine level (from 7.23 to 5.67 ng/mL) and increased thyrotropin level (from 7.88 to 12.86 mU/L) for female rats. PBEB consequently reduced thyroid weight and altered its morphology with more depleted follicles. Overall, our study provides the first account of evidence on PBEB exerted thyroid disruption, transcriptome aberration and morphological alterations, facilitating health risk assessment of PBEB and structurally related NBFRs.
Funding Information
  • Welch Foundation
  • Ministry of Education of the People's Republic of China (2020FZZX001-06)
  • National Natural Science Foundation of China (21876153, 91643107)

This publication has 60 references indexed in Scilit: